New Release: Australian Prescriber December Issue
Explore the new Australian Prescriber issue: Volume 46 Issue 4.
The December edition of Australian Prescriber covers the common practice-based issue of off-label prescribing, a therapeutic review of gabapentinoids, physical health monitoring for people with schizophrenia and more.
An editorial on the updated National Medicines Policy provides an expectation for the future of quality use of medicines in Australia and the much-loved ‘Top 10 drugs’ lists* return.
Explore the December issue:
- National Medicines Policy 2.0
- Physical health monitoring for people with schizophrenia
- Gabapentinoids: a therapeutic review
- Ongoing challenges of off-label prescribing
- Valediction: John Dowden
- Herpes zoster (shingles) vaccination update
- Top 10 drugs 2021-22
- Top 10 drugs 2022-23
New drugs:
- Tirzepatide for type 2 diabetes
- Pneumococcal 15-valent and 20-valent conjugate vaccines
- Vericiguat for chronic heart failure
*Data are based on PBS and RPBS prescriptions from 2021-22 and 2022-23 financial years.
Australian Prescriber is Australia’s free, national, independent peer-reviewed journal providing critical commentary on drugs and therapeutics. Published bimonthly, it supports health professionals to make informed choices when prescribing.
The next Australian Prescriber podcast episode will be released on 19 December 2023, with more releases to come in 2024. If you haven’t already, listen to the latest episodes on Therapeutic Guidelines: Diabetes and COVID-19 vaccines in 2023.
Are you a subscriber? Get the latest updates for free. Subscribe now.
Published 12/12/2023